OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy
Peng Wu, Arun Rangaswami
Current Oncology Reports (2022) Vol. 24, Iss. 9, pp. 1209-1218
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Alex Clavería-Cabello, José M. Herranz, M. Ujúe Latasa, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. 989-1005
Open Access | Times Cited: 23

Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics
Yanlin Yang, Haoru Wang, Jiajun Si, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 4

Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids
Thomas A. Kluiver, Yuyan Lu, Stephanie A. Schubert, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

Mimicking cancer therapy in an agent-based model: the case of hepatoblastoma
Alessandro Ravoni, Enrico Mastrostefano, Roland Kappler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Hepatoblastoma: From Molecular Mechanisms to Therapeutic Strategies
Fan Ling, Jintong Na, Tieliu Shi, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 149-149
Open Access

An update on diagnosis and treatment of hepatoblastoma
Yinbiao Cao, Shurui Wu, Haowen Tang
BioScience Trends (2023) Vol. 17, Iss. 6, pp. 445-457
Open Access | Times Cited: 9

Intratumoral CXCR4hi neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma
Zhengjing Lu, Xiaolin Wang, Jun Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Sporoderm‐broken spores of Ganoderma lucidum modulate hepatoblastoma malignancy by regulating RACK1‐mediated autophagy and tumour immunity
Rui Shen, Ge Yang, Yunpeng Qin, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 2

Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part I
Yi Dong, Andrius Čekuolis, Dagmar Schreiber-Dietrich, et al.
Diagnostics (2023) Vol. 13, Iss. 23, pp. 3568-3568
Open Access | Times Cited: 5

State of the art and perspectives in pediatric hepatocellular carcinoma
Graziana Digiacomo, Roberta Pia Serra, Elena Turrini, et al.
Biochemical Pharmacology (2022) Vol. 207, pp. 115373-115373
Closed Access | Times Cited: 8

Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer
Daolin Zeng, Chunlin Yu, Shiyao Chen, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Onkologische Erkrankungen beim Neugeborenen
Christian Flotho
Neonatologie Scan (2024) Vol. 13, Iss. 02, pp. 151-164
Closed Access | Times Cited: 1

Precision Oncology in Pediatric Cancer Surgery
William G. Lee, Eugene S. Kim
Surgical Oncology Clinics of North America (2023) Vol. 33, Iss. 2, pp. 409-446
Closed Access | Times Cited: 3

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
Tan Xie, Dongliang Hou, Jiaxiang Wang, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 2

Everolimus inhibits hepatoblastoma by inducing autophagy‐dependent ferroptosis
Haijin Huang, Jinlong Yan, Xianyun Xu, et al.
Drug Development Research (2023) Vol. 85, Iss. 1
Closed Access | Times Cited: 2

Hepatic Tumors in Childhood
Dolores López‐Terrada, Rita Alaggio
Springer eBooks (2024), pp. 575-626
Closed Access

First Transcriptome Analysis of Hepatoblastoma in Brazil: Unraveling the Pivotal Role of Noncoding RNAs and Metabolic Pathways
Talita Ferreira Marques Aguiar, Maria Prates Rivas, Edson Mário de Andrade Silva, et al.
Biochemical Genetics (2024)
Open Access

From diagnosis to therapy: The critical role of lncRNAs in hepatoblastoma
A. Khuzaim Alzahrani, Abida Khan, Neelam Singla, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155412-155412
Closed Access

Gamma-butyrobetaine hydroxylase (BBOX1) exerts suppressive effects on HepG2 hepatoblastoma cells
Yuling Zhan, Xiang Dong, Minghui Yang, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access

Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis
Chengnan Guo, Zhenqiu Liu, Xin Zhang, et al.
Hepatology International (2024) Vol. 19, Iss. 1, pp. 156-165
Closed Access

Page 1 - Next Page

Scroll to top